Search Results 931-940 of 17039 for monoclonal antibody

1. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia - Mayo Clinic

   At least 14 days since prior monoclonal antibody therapy; No more than 1 prior autologous or allogeneic hematopoietic stem cell transplantation. No evidence ...

2. Brandon Wilbanks: Finding DNA Molecules That Can Transport Drugs Inside Cells - Student Research - Mayo Clinic College of Medicine & Science

   Because antibodies are used as therapies — in cancer, autoimmune diseases, transplant medicine, multiple sclerosis, gastric diseases and other areas — the ...

3. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

   Prior monoclonal antibody within 4 weeks prior to study Day 1 (2 weeks for RS participants) or who has not recovered (i.e. ≤ Grade 1 or at baseline) from ...

4. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

   composition to monoclonal antibodies or any excipient of HFB301001; - Known active malignancy, with the exception of the specific cancer under investigation

5. Therapeutic Drug Monitoring of Pembrolizumab and Nivolumab to Determine Dosages for Cancer Treatment - Mayo Clinic

   Adults who are just initiating monoclonal antibody therapy with pembrolizumab or nivolumab for melanoma or non-small cell lung cancer. Exclusion Criteria ...

6. Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

   No history of severe allergic reactions to monoclonal antibodies. Female ... Hepatitis C as indicated by anti-hepatitis C antibody positivity; if a participant is ...

7. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

   ... antibody, 1 immunomodulatory imide drug (IMiD) ... monoclonal protein, and skin changes) 2 ... antibody-drug conjugates are not excluded) 6. History ...

8. A Study of the Safety and Effectiveness of QPI-1002 for the Prevention of Delayed Graft Function in Transplant Recipients from Older Kidney Donors who have Died - Mayo Clinic

   ... monoclonal antibodies per center standard of care. Must be up-to-date on ... Has a positive T- or B-cell flow cross-match AND donor specific anti-HLA antibody ...

9. Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) - Mayo Clinic

   Previous severe hypersensitivity reaction to another monoclonal antibody (mAb). Active autoimmune disease or a documented history of autoimmune disease or ...

10. Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

    ... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...